Society for Immunotherapy of Cancer - 2024 Fellowships
Event details
| Date | 18.03.2024 |
| Category | Conferences - Seminars |
The Society for Immunotherapy of Cancer’s (SITC) Fellowships program supports the development of early career scientists in the field to cultivate the next generation of cancer immunotherapy experts.
Please note that applicants must be current SITC members.
In 2024, four fellowship programs are open to international applicants.
SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship
This cancer immunotherapy translational fellowship aims to support an MD, PhD, or combined MD/PhD individual with a vested interest in furthering the research and translation of cancer immunotherapy.
- Funding: $200,000
- Duration: 2 years
- Eligibility: Hold an MD, PhD or combined MD/PhD degree, currently in a postdoc or comparable position, and have a pre-arranged fellowship mentor.
- Full info here
SITC-MRA Women in Melanoma Fellowship
This fellowship supports a woman who has an MD, PhD, or combined MD/PhD degree with a vested interest in furthering research in cancer immunotherapy for the treatment of patients with melanoma.
- Funding: $200,000
- Duration: 2 years
- Eligibility: Hold an MD, PhD or combined MD/PhD degree, currently hold a position at an academic institution as an Assistant Professor (or equivalent) and be within four years of appointment
- Full info here
SITC-Merck Cancer Immunotherapy Clinical Fellowship
This clinical fellowship supports an MD or combined MD/PhD with a vested interest in furthering cancer immunotherapy research and translational immunotherapeutic approaches.
- Funding: $100,000
- Duration: 1 year
- Eligibility: Hold an MD or combined MD/PhD, currently hold a postdoc or tenure-track position, have a pre-arranged fellowship mentor
- Full info here
SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship
This fellowship provides support to an individual with an MD (or equivalent) or combined MD/PhD degree with a vested interest in furthering the research and translation of adverse events in cancer immunotherapy.
- Funding: $40,000
- Duration: 1 year
- Eligibility: Hold an MD or combined MD/PhD, currently hold a postdoc or tenure-track position, have a pre-arranged fellowship mentor.
- Full info here
How to Apply: Applications are submitted through dedicated online platforms: for the SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational Fellowship, SITC-MRA Women in Melanoma Fellowship and SITC-Merck Cancer Immunotherapy Clinical Fellowship the portal can be found here. For the The SITC-Mallinckrodt Pharmaceuticals Adverse Events in Cancer Immunotherapy Clinical Fellowship the portal can be found here.
Application Deadline: 18 March 2024
Further information
- More information about the program is available here.
- The application portals can be found here and here.
- For any other questions, please contact the Research Office
Practical information
- General public
- Free